Affiliation:
1. Federal State Budgetary Institution “Centre for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical Biological Agency
2. Federal State Autonomous Educational Institution for Higher Education “Peoples’ Friendship University of Russia”
Abstract
Primary liver tumors are one of the most common types of malignant neoplasms. Surgical excision is still the most effective treatment in the early stages of the disease, however in most cases early diagnosis is difficult. Moreover, even if the treatment is carried out according to a radical program, the risk of relapse remains extremely high. In this regard, the search for new strategies for the treatment of liver malignancies that differ from traditional methods of treatment is not terminated. One of such promising approaches is immunotherapy. The present review is devoted to the current understanding of the mechanisms of action and the available clinical experience in the use of immunotherapy approaches in the treatment of liver malignancies. Combining different types of immunotherapy or combining immunotherapy with traditional therapeutic approaches can facilitate a synergistic effect and contribute to the development of personalized medicine.
Publisher
LLC Global Media Technology
Reference48 articles.
1. Chekmazov IA, Ivanikov IO, Sapronov GV, Kirillova NCh, Vinogradova NN. Liver cancer: etiology, pathogenesis, results of long-term clinical and epidemiological observation (in Russian only). Russian journal of Evidence-based gastroenterology = Dokazatel’naya gastroenterologiya. 2019;8(1):5-15. (In Russ.) Doi: 10.17116/dokgastro201980115@@ Chekmazov I. A., Ivanikov I. O., Sapronov G. V., Kirillova N. Ch., Vinogradova N. N. Rak pecheni: etiologiya, patogenez, itogi dlitel'nogo kliniko-epidemiologicheskogo nablyudeniya. Dokazatel'naya gastroenterologiya. 2019;8(1):5-15.
2. Shchegolev AI, Tumanova UN, Mishnev OD. Risk factors of hepatocellular carcinoma. International journal of applied and fundamental research. 2018; 9:164-169. (In Russ.)@@ Shchegolev A. I., Tumanova U. N., Mishnev O. D. Faktory riska razvitiya gepatotsellyulyarnoi kartsinomy. Mezhdunarodnyi zhurnal prikladnykh i fundamental'nykh issledovanii. 2018;9:164-169.
3. Ozakyol A. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). J Gastrointest Canc. 2017; 48:238-240. Doi: 10.1007/s12029-017-9959-0.
4. Merabishvili V.M., Chepik O.f., Merabishvili E. N. Dynamics of observed and relative survival of patients with primary liver cancer on the population level according to disease stage and histological structure. Siberian journal of oncology. 2015;1(4):5-11. (In Russ.)@@ Merabishvili V. M., Chepik O. F., & Merabishvili E. N. Dinamika nablyudaemoi i otnositel'noi vyzhivaemosti bol'nykh pervichnym rakom pecheni na populyatsionnom urovne s uchetom stadii zabolevaniya i gistologicheskoi struktury. Sibirskii onkologicheskii zhurnal. 2015; (4), 5-11.
5. Moini M., Schilsky M. L., Tichy E. M. Review on immunosuppression in liver transplantation. World journal of hepatology. 2015; 7(10):1355. Doi: 10.4254/wjh.v7.i10.1355